BevacizumabLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1942卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32684-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：75 / 75

相关论文

共 50 条

[21] Aflibercept/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2023, 1957 (1) :21-21

[22] Atezolizumab/BevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2025, 2041 (1) :71-71

[23] Atezolizumab/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1922 (1) :104-104

[24] Atezolizumab/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1930 (1) :102-102

[25] Acetazolamide/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1913 (1) :18-18

[26] Atezolizumab/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1912 (1) :100-100

[27] Atezolizumab/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2024, 2025 (1) :60-60

[28] Antiglaucoma/acetazolamide/bevacizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1926 (1) :52-52

[29] Atezolizumab/bevacizumabLack of efficacy and recurrent pneumothorax: case report [J].

Reactions Weekly, 2024, 2035 (1) :86-86

[30] BevacizumabLack of efficacy and off-label use: case report [J].

Reactions Weekly, 2025, 2042 (1) :81-81

← 1 2 3 4 5 →